These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6826486)

  • 1. The penetration of amoxycillin/clavulanic acid into peritoneal fluid.
    Wise R; Donovan IA; Drumm J; Andrews JM; Stephenson P
    J Antimicrob Chemother; 1983 Jan; 11(1):57-60. PubMed ID: 6826486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal penetration of ticarcillin/clavulanic acid (Timentin).
    Manek N; Wise R; Donovan IA
    J Antimicrob Chemother; 1987 Mar; 19(3):363-6. PubMed ID: 3494723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of amoxycillin/clavulanic acid in serum and ascitic fluid in cirrhotic patients.
    Grange JD; Gouyette A; Gutmann L; Amiot X; Kitzis MD; Islam S; Acar JF; Jaillon P
    J Antimicrob Chemother; 1989 Apr; 23(4):605-11. PubMed ID: 2745264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum.
    Houang ET; Colley N; Chapman M
    Antimicrob Agents Chemother; 1985 Jul; 28(1):165-6. PubMed ID: 2994556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of amoxycillin and clavulanic acid into bone.
    Grimer RJ; Karpinski MR; Andrews JM; Wise R
    Chemotherapy; 1986; 32(3):185-91. PubMed ID: 3486754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of clavulanic acid, given in combination with amoxycillin, in volunteers.
    Nilsson-Ehle I; Fellner H; Hedström SA; Nilsson-Ehle P; Sjövall J
    J Antimicrob Chemother; 1985 Oct; 16(4):491-8. PubMed ID: 4066561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of amoxycillin, ticarcillin and clavulanic acid into lymph after intravenous infusion in rabbits to simulate human serum pharmacokinetics.
    Woodnutt G; Berry V; Kernutt I; Mizen L
    J Antimicrob Chemother; 1990 Nov; 26(5):695-704. PubMed ID: 2079451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid.
    Wise R; Bennett SA; Dent J
    J Antimicrob Chemother; 1984 Jun; 13(6):603-10. PubMed ID: 6469882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral augmentin: pharmacokinetics.
    Staniforth DH; Jackson D; Horton R; Davies B
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):430-4. PubMed ID: 6490225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study of a paediatric formulation of amoxycillin and clavulanic acid in children.
    van Niekerk CH; van den Ende J; Hundt HK; Louw EA
    Eur J Clin Pharmacol; 1985; 29(2):235-9. PubMed ID: 3908124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of a syrup formulation of amoxycillin-potassium clavulanate in children.
    Schaad UB; Casey PA; Ravenscroft AT
    J Antimicrob Chemother; 1986 Mar; 17(3):341-5. PubMed ID: 3700293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid in in-vitro kinetic models.
    White AR; Stokes DH; Slocombe B; Sutherland R
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():227-32. PubMed ID: 3980328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amoxycillin/clavulanic acid: the effect of probenecid.
    Staniforth DH; Jackson D; Clarke HL; Horton R
    J Antimicrob Chemother; 1983 Sep; 12(3):273-5. PubMed ID: 6630111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal effects of amoxycillin/clavulanic acid against intracellular Legionella pneumophila in tissue culture studies.
    Stokes DH; Wilkinson MJ; Tyler J; Slocombe B; Sutherland R
    J Antimicrob Chemother; 1989 Apr; 23(4):547-56. PubMed ID: 2745260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of concentrations of two doses of clavulanic acid (200 and 400 milligrams) administered with amoxicillin (2,000 milligrams) in tissues of patients undergoing colorectal surgery.
    Martin C; Mallet MN; Sastre B; Viviand X; Martin A; De Micco P; Gouin F
    Antimicrob Agents Chemother; 1995 Jan; 39(1):94-8. PubMed ID: 7695337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat.
    Catherall EJ; Irwin R; Mizen LW
    J Antimicrob Chemother; 1991 Jan; 27(1):117-26. PubMed ID: 2050588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of amoxycillin, clavulanate and the combination by faecal preparations from volunteers.
    Welling GW; Groen G
    J Antimicrob Chemother; 1990 Feb; 25(2):301-2. PubMed ID: 2329109
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue and serum concentrations of amoxycillin and clavulanic acid in patients having reconstructive vascular surgery.
    Earnshaw JJ; Slack RC; Makin GS; Hopkinson BR
    J Int Med Res; 1987; 15(4):205-11. PubMed ID: 3653499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tissue penetration of Timentin: a simultaneous study of serum, urine, lymph, suction blister and subcutaneous thread fluid.
    Walstad RA; Hellum KB; Thurmann-Nielsen E; Dale LG
    J Antimicrob Chemother; 1986 May; 17 Suppl C():71-80. PubMed ID: 3722049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration into lung tissue after intravenous administration of amoxycillin/clavulanate.
    Cox AL; Meewis JM; Horton R
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():87-91. PubMed ID: 2606823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.